Comparative Pharmacology
Head-to-head clinical analysis: DOPTELET SPRINKLE versus ELTROMBOPAG.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DOPTELET SPRINKLE versus ELTROMBOPAG.
DOPTELET SPRINKLE vs ELTROMBOPAG
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
DOPTELET (avatrombopag) is a thrombopoietin receptor agonist that binds to and activates the thrombopoietin receptor on megakaryocytes and megakaryocyte precursor cells, leading to differentiation, proliferation, and increased platelet production.
Eltrombopag is a small-molecule agonist of the thrombopoietin (TPO) receptor, activating the JAK/STAT signaling pathway to stimulate megakaryocyte proliferation and differentiation, thereby increasing platelet production.
10 mg (5 capsules) orally once daily for 5 consecutive days. Two to 4 hours before planned procedure, total dose should be taken 5 days prior to the procedure.
50 mg orally once daily; adjust dose based on platelet response. Maximum dose 75 mg/day.
None Documented
None Documented
Clinical Note
moderateEltrombopag + Deferasirox
"The serum concentration of Deferasirox can be increased when it is combined with Eltrombopag."
Clinical Note
moderateEltrombopag + Tenofovir disoproxil
"The metabolism of Tenofovir disoproxil can be decreased when combined with Eltrombopag."
Clinical Note
moderateEltrombopag + Clotrimazole
"The metabolism of Clotrimazole can be decreased when combined with Eltrombopag."
Clinical Note
moderateEltrombopag + Ticlopidine
Terminal half-life approximately 31-35 hours; supports once-daily dosing
~21–32 hours in healthy subjects; 26–35 hours in ITP patients. Supports once-daily dosing.
Fecal (approx. 59%), renal (approx. 31%) as unchanged drug and metabolites
Fecal (≥59% as unchanged drug, ~31% as metabolites); renal (~20% as metabolites, <1% as unchanged drug). Total excretion: feces ~88%, urine ~13%.
Category C
Category C
Thrombopoietin Receptor Agonist
Thrombopoietin Receptor Agonist
"The metabolism of Ticlopidine can be decreased when combined with Eltrombopag."